P/F BAKKAFROST financials
P/F BAKKAFROST
2138007LH7OP4V112978 | Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Revenue | DKK 7.33B | DKK 7.14B |
| Other income | DKK 79.4M | DKK 37.9M |
| Employee benefits expense | DKK 881.9M | DKK 862.7M |
| Raw materials & consumables used | DKK 1.49B | DKK 2.40B |
| Operating profit (EBIT) | DKK 1.55B | DKK 1.54B |
| Finance costs | DKK 199.5M | DKK 184.7M |
| Profit before tax | DKK 851.6M | DKK 1.15B |
| Income tax expense | DKK 206.8M | DKK 193.1M |
| Profit for the year | DKK 644.8M | DKK 955.2M |
| — attributable to owners | DKK 656.6M | DKK 955.6M |
| — attributable to NCI | -DKK 11.8M | -DKK 358.0K |
| Total comprehensive income | DKK 782.8M | DKK 1.01B |
| Per share | ||
| Basic EPS | DKK 10.88 | DKK 16.14 |
| Free cash flow / share | DKK 22.42 | DKK -0.67 |
| Cash flow statement | ||
| Net cash from operating activities | DKK 2.35B | DKK 1.02B |
| Net cash from investing activities | -DKK 1.01B | -DKK 1.04B |
| Purchase of PP&E (capex) | DKK 1.03B | DKK 1.06B |
| Net cash from financing activities | -DKK 1.27B | -DKK 286.8M |
| Dividends paid | DKK 515.3M | DKK 591.4M |
| Lease liability payments | DKK 126.1M | DKK 130.7M |
| Balance sheet | ||
| Total assets | DKK 17.67B | DKK 17.84B |
| Non-current assets | DKK 12.50B | DKK 11.94B |
| Property, plant & equipment | DKK 6.73B | DKK 6.22B |
| Right-of-use assets | DKK 320.8M | DKK 413.3M |
| Intangible assets & goodwill | DKK 4.52B | DKK 4.51B |
| Current assets | DKK 5.18B | DKK 5.90B |
| Inventories | DKK 670.9M | DKK 1.15B |
| Trade & other receivables | DKK 674.8M | DKK 850.3M |
| Cash & equivalents | DKK 480.5M | DKK 411.7M |
| Total equity | DKK 11.16B | DKK 10.87B |
| Non-controlling interests | -DKK 8.7M | DKK 3.1M |
| Non-current liabilities | DKK 5.75B | DKK 6.23B |
| Long-term borrowings | DKK 3.48B | DKK 3.94B |
| Lease liabilities (non-current) | DKK 233.9M | DKK 331.1M |
| Current liabilities | DKK 766.5M | DKK 747.0M |
| Lease liabilities (current) | DKK 64.9M | DKK 65.8M |
| Deferred tax liabilities | DKK 2.04B | DKK 1.95B |
| Derived metrics | ||
| Free cash flow | DKK 1.33B | -DKK 39.4M |
| Operating margin | 21.1% | 21.6% |
| Net margin | 8.8% | 13.4% |
| Return on equity | 5.8% | 8.8% |
| Cash conversion ratio | 3.65× | 1.07× |
| Capex coverage | 2.29× | 0.96× |
| Other reported items | ||
| Adjustments For Decrease Increase In Inventories | DKK 305.9M | -DKK 613.2M |
| Adjustments For Decrease Increase In Trade and Other Receivables | DKK 77.2M | DKK 114.0M |
| Adjustments For Depreciation and Amortisation Expense and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | DKK 704.3M | DKK 637.2M |
| Adjustments For Gains Losses On Change In Fair Value Less Costs To Sell Biological Assets | -DKK 368.9M | -DKK 141.7M |
| Adjustments For Undistributed Profits of Investments Accounted For Using Equity Method | DKK 47.0M | DKK 70.7M |
| Adjustments For Unrealised Foreign Exchange Losses Gains | DKK 81.4M | DKK 46.4M |
| Cash Flows From Used In Increase Decrease In Current Borrowings | -DKK 464.9M | DKK 546.2M |
| Changes In Equity | DKK 290.8M | DKK 470.0M |
| Comprehensive Income Attributable To Noncontrolling Interests | -DKK 11.8M | -DKK 358.0K |
| Comprehensive Income Attributable To Owners of Parent | DKK 794.6M | DKK 1.01B |
| Current Biological Assets | DKK 3.14B | DKK 3.34B |
| Current Derivative Financial Assets | DKK 0 | DKK 374.0K |
| Current Derivative Financial Liabilities | DKK 3.4M | DKK 0 |
| Current Tax Assets Current | DKK 0 | DKK 56.1M |
| Current Tax Liabilities Current | DKK 186.4M | DKK 210.4M |
| Deferred Tax Assets | DKK 590.3M | DKK 512.5M |
| Depreciation Expense | DKK 704.3M | DKK 637.2M |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners | — | DKK 501.0M |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners Per Share | DKK 8.44 | — |
| Equity and Liabilities | DKK 17.67B | DKK 17.84B |
| Finance Income | DKK 18.6M | DKK 20.8M |
| Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss | DKK 34.9M | DKK 2.8M |
| Gains Losses On Fair Value Adjustment Biological Assets | -DKK 368.9M | -DKK 141.7M |
| Income Tax Relating To Cash Flow Hedges of Other Comprehensive Income | -DKK 636.0K | -DKK 976.0K |
| Income Taxes Paid Refund Classified As Operating Activities | DKK 209.5M | DKK 197.0M |
| Increase Decrease In Cash and Cash Equivalents | DKK 68.8M | -DKK 307.9M |
| Increase Decrease Through Transactions With Owners | -DKK 492.0M | -DKK 539.5M |
| Increase Decrease Through Treasury Share Transactions | -DKK 8.8M | DKK 11.1M |
| Investments In Associates Accounted For Using Equity Method | DKK 333.5M | DKK 287.7M |
| Issue of Equity | DKK 31.4M | DKK 40.5M |
| Issued Capital | DKK 59.3M | DKK 59.2M |
| Liabilities | DKK 6.52B | DKK 6.98B |
| Noncurrent Financial Assets | DKK 924.8M | DKK 801.2M |
| Noncurrent Investments Other Than Investments Accounted For Using Equity Method | DKK 983.0K | DKK 983.0K |
| Noncurrent Receivables | DKK 0 | DKK 0 |
| Other Comprehensive Income | DKK 138.0M | DKK 54.3M |
| Other Comprehensive Income Before Tax Cash Flow Hedges | -DKK 4.2M | -DKK 6.4M |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | DKK 134.0M | DKK 58.7M |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | DKK 138.0M | DKK 54.3M |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | DKK 0 | DKK 0 |
| Other Current Liabilities | DKK 78.7M | DKK 83.2M |
| Other Current Receivables | DKK 212.5M | DKK 94.0M |
| Other Equity Interest | DKK 11.11B | DKK 10.80B |
| Other Expense By Nature | DKK 2.07B | DKK 1.88B |
| Other Finance Cost | DKK 8.1M | DKK 10.5M |
| Other Intangible Assets | DKK 4.52B | DKK 4.51B |
| Proceeds From Issuing Shares | DKK 31.4M | DKK 40.5M |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | DKK 4.2M | DKK 2.1M |
| Share of Profit Loss of Associates Accounted For Using Equity Method | DKK 47.0M | DKK 70.7M |
| Tax Expense Other Than Income Tax Expense | DKK 221.9M | DKK 152.8M |
| Trade and Other Current Payables To Trade Suppliers | DKK 433.1M | DKK 387.6M |
Every line item above is a fact tagged in P/F BAKKAFROST's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (DKK), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.